Tilray Brands, Inc. (NASDAQ:TLRY – Get Free Report) shares were up 8.1% during trading on Friday after TD Securities upgraded the stock to a strong-buy rating. The company traded as high as $4.56 and last traded at $4.54. Approximately 6,278,281 shares traded hands during mid-day trading, an increase of 46% from the average session volume of 4,310,874 shares. The stock had previously closed at $4.20.
Other equities analysts have also recently issued reports about the company. ATB Cormark Capital Markets lowered their price objective on Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 2nd. Wall Street Zen cut shares of Tilray Brands from a “hold” rating to a “sell” rating in a report on Saturday. Weiss Ratings cut shares of Tilray Brands from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 13th. TD Cowen cut their target price on shares of Tilray Brands from $7.00 to $5.00 and set a “buy” rating for the company in a research report on Tuesday, July 14th. Finally, Roth Capital upgraded shares of Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 target price for the company in a research note on Thursday, April 2nd. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $11.00.
Get Our Latest Report on Tilray Brands
Trending Headlines about Tilray Brands
- Positive Sentiment: Unusual options activity provided a bullish trading signal: investors purchased 23,521 TLRY call options, approximately 82% above the stock’s typical daily call volume. This suggests increased speculative interest in further gains.
- Positive Sentiment: Jefferies reiterated its Buy rating, saying Tilray is making progress in its transition toward a diversified consumer-products company. The firm’s view supports the potential for longer-term value from Tilray’s cannabis, beverage and other businesses. Tilray Brands seen creating long-term value through diversified platform, Jefferies says
- Neutral Sentiment: Southern Glazer’s Wine & Spirits completed its acquisition of substantially all of Eagle Rock Distributing’s Colorado assets. The transaction could be relevant to Tilray’s beverage-distribution strategy if it affects industry relationships, but the announcement did not directly identify Tilray or quantify an impact on its results. Southern Glazer’s Wine & Spirits Closes Acquisition of Eagle Rock Distributing Co.
- Negative Sentiment: Jefferies lowered its price target to $19 and reduced fiscal 2027 and 2028 EBITDA estimates after Tilray’s guidance for fiscal 2027 adjusted EBITDA of $68 million to $75 million came in below the roughly $84 million consensus estimate. The lower forecasts highlight continuing profitability concerns.
- Negative Sentiment: Tilray remains in a prolonged downtrend, having lost substantial value this year alongside other cannabis stocks. Its weak recent momentum and history of quarterly losses remain risks despite the current rebound. Tilray Brands stock continues its downward spiral
Institutional Investors Weigh In On Tilray Brands
Several hedge funds and other institutional investors have recently made changes to their positions in TLRY. Tudor Investment Corp ET AL purchased a new position in shares of Tilray Brands in the third quarter worth approximately $518,000. Hillsdale Investment Management Inc. bought a new stake in Tilray Brands during the fourth quarter valued at approximately $4,855,000. IFP Advisors Inc increased its holdings in Tilray Brands by 14.3% during the fourth quarter. IFP Advisors Inc now owns 60,318 shares of the company’s stock valued at $545,000 after buying an additional 7,541 shares during the last quarter. State of New Jersey Common Pension Fund D purchased a new stake in Tilray Brands during the fourth quarter valued at approximately $346,000. Finally, Marex Group plc bought a new position in Tilray Brands in the second quarter worth approximately $40,000. Hedge funds and other institutional investors own 9.35% of the company’s stock.
Tilray Brands Stock Up 8.1%
The company has a debt-to-equity ratio of 0.22, a current ratio of 2.21 and a quick ratio of 1.66. The firm has a market capitalization of $529.14 million, a P/E ratio of -4.20 and a beta of 1.89. The company’s 50-day simple moving average is $4.67 and its two-hundred day simple moving average is $6.26.
Tilray Brands (NASDAQ:TLRY – Get Free Report) last issued its quarterly earnings data on Tuesday, July 28th. The company reported ($0.43) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.42). The business had revenue of $281.71 million for the quarter, compared to the consensus estimate of $246.30 million. Tilray Brands had a negative net margin of 13.11% and a negative return on equity of 7.76%. As a group, research analysts expect that Tilray Brands, Inc. will post -0.34 earnings per share for the current year.
About Tilray Brands
Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.
Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.
See Also
- Five stocks we like better than Tilray Brands
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.
